COVID-19 patients age, comorbidity profiles and clinical presentation related to the SARS-CoV-2 UK-variant spread in the Southeast of France
Abstract The variant 20I/501Y.V1, associated to a higher risk of transmissibility, emerged in Nice city (Southeast of France, French Riviera) during January 2021. The pandemic has resumed late December 2020 in this area. A high incidence rate together with a fast turn-over of the main circulating va...
Guardado en:
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ccfe3dbe8a484c0c8c3800949a624648 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:ccfe3dbe8a484c0c8c3800949a624648 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:ccfe3dbe8a484c0c8c3800949a6246482021-12-02T15:31:27ZCOVID-19 patients age, comorbidity profiles and clinical presentation related to the SARS-CoV-2 UK-variant spread in the Southeast of France10.1038/s41598-021-95067-72045-2322https://doaj.org/article/ccfe3dbe8a484c0c8c3800949a6246482021-09-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-95067-7https://doaj.org/toc/2045-2322Abstract The variant 20I/501Y.V1, associated to a higher risk of transmissibility, emerged in Nice city (Southeast of France, French Riviera) during January 2021. The pandemic has resumed late December 2020 in this area. A high incidence rate together with a fast turn-over of the main circulating variants, provided us the opportunity to analyze modifications in clinical profile and outcome traits. We performed an observational study in the University hospital of Nice from December 2020 to February 2021. We analyzed data of sequencing of SARS-CoV-2 from the sewage collector and PCR screening from all positive samples at the hospital. Then, we described the characteristics of all COVID-19 patients admitted in the emergency department (ED) (n = 1247) and those hospitalized in the infectious diseases ward or ICU (n = 232). The UK-variant was absent in this area in December, then increasingly spread in January representing 59% of the PCR screening performed mid-February. The rate of patients over 65 years admitted to the ED decreased from 63 to 50% (p = 0.001). The mean age of hospitalized patients in the infectious diseases ward decreased from 70.7 to 59.2 (p < 0.001) while the proportion of patients without comorbidity increased from 16 to 42% (p = 0.007). Spread of the UK-variant in the Southeast of France affects younger and healthier patients.Johan CourjonJulie ContentiElisa DemonchyJacques LevrautPascal BarbryGéraldine RiosJean DellamonicaDavid ChirioCaroline BonnefoyValérie GiordanengoMichel CarlesNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-6 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Johan Courjon Julie Contenti Elisa Demonchy Jacques Levraut Pascal Barbry Géraldine Rios Jean Dellamonica David Chirio Caroline Bonnefoy Valérie Giordanengo Michel Carles COVID-19 patients age, comorbidity profiles and clinical presentation related to the SARS-CoV-2 UK-variant spread in the Southeast of France |
description |
Abstract The variant 20I/501Y.V1, associated to a higher risk of transmissibility, emerged in Nice city (Southeast of France, French Riviera) during January 2021. The pandemic has resumed late December 2020 in this area. A high incidence rate together with a fast turn-over of the main circulating variants, provided us the opportunity to analyze modifications in clinical profile and outcome traits. We performed an observational study in the University hospital of Nice from December 2020 to February 2021. We analyzed data of sequencing of SARS-CoV-2 from the sewage collector and PCR screening from all positive samples at the hospital. Then, we described the characteristics of all COVID-19 patients admitted in the emergency department (ED) (n = 1247) and those hospitalized in the infectious diseases ward or ICU (n = 232). The UK-variant was absent in this area in December, then increasingly spread in January representing 59% of the PCR screening performed mid-February. The rate of patients over 65 years admitted to the ED decreased from 63 to 50% (p = 0.001). The mean age of hospitalized patients in the infectious diseases ward decreased from 70.7 to 59.2 (p < 0.001) while the proportion of patients without comorbidity increased from 16 to 42% (p = 0.007). Spread of the UK-variant in the Southeast of France affects younger and healthier patients. |
format |
article |
author |
Johan Courjon Julie Contenti Elisa Demonchy Jacques Levraut Pascal Barbry Géraldine Rios Jean Dellamonica David Chirio Caroline Bonnefoy Valérie Giordanengo Michel Carles |
author_facet |
Johan Courjon Julie Contenti Elisa Demonchy Jacques Levraut Pascal Barbry Géraldine Rios Jean Dellamonica David Chirio Caroline Bonnefoy Valérie Giordanengo Michel Carles |
author_sort |
Johan Courjon |
title |
COVID-19 patients age, comorbidity profiles and clinical presentation related to the SARS-CoV-2 UK-variant spread in the Southeast of France |
title_short |
COVID-19 patients age, comorbidity profiles and clinical presentation related to the SARS-CoV-2 UK-variant spread in the Southeast of France |
title_full |
COVID-19 patients age, comorbidity profiles and clinical presentation related to the SARS-CoV-2 UK-variant spread in the Southeast of France |
title_fullStr |
COVID-19 patients age, comorbidity profiles and clinical presentation related to the SARS-CoV-2 UK-variant spread in the Southeast of France |
title_full_unstemmed |
COVID-19 patients age, comorbidity profiles and clinical presentation related to the SARS-CoV-2 UK-variant spread in the Southeast of France |
title_sort |
covid-19 patients age, comorbidity profiles and clinical presentation related to the sars-cov-2 uk-variant spread in the southeast of france |
publisher |
Nature Portfolio |
publishDate |
2021 |
url |
https://doaj.org/article/ccfe3dbe8a484c0c8c3800949a624648 |
work_keys_str_mv |
AT johancourjon covid19patientsagecomorbidityprofilesandclinicalpresentationrelatedtothesarscov2ukvariantspreadinthesoutheastoffrance AT juliecontenti covid19patientsagecomorbidityprofilesandclinicalpresentationrelatedtothesarscov2ukvariantspreadinthesoutheastoffrance AT elisademonchy covid19patientsagecomorbidityprofilesandclinicalpresentationrelatedtothesarscov2ukvariantspreadinthesoutheastoffrance AT jacqueslevraut covid19patientsagecomorbidityprofilesandclinicalpresentationrelatedtothesarscov2ukvariantspreadinthesoutheastoffrance AT pascalbarbry covid19patientsagecomorbidityprofilesandclinicalpresentationrelatedtothesarscov2ukvariantspreadinthesoutheastoffrance AT geraldinerios covid19patientsagecomorbidityprofilesandclinicalpresentationrelatedtothesarscov2ukvariantspreadinthesoutheastoffrance AT jeandellamonica covid19patientsagecomorbidityprofilesandclinicalpresentationrelatedtothesarscov2ukvariantspreadinthesoutheastoffrance AT davidchirio covid19patientsagecomorbidityprofilesandclinicalpresentationrelatedtothesarscov2ukvariantspreadinthesoutheastoffrance AT carolinebonnefoy covid19patientsagecomorbidityprofilesandclinicalpresentationrelatedtothesarscov2ukvariantspreadinthesoutheastoffrance AT valeriegiordanengo covid19patientsagecomorbidityprofilesandclinicalpresentationrelatedtothesarscov2ukvariantspreadinthesoutheastoffrance AT michelcarles covid19patientsagecomorbidityprofilesandclinicalpresentationrelatedtothesarscov2ukvariantspreadinthesoutheastoffrance |
_version_ |
1718387170460303360 |